# AGILON HEALTH INC (AGL)

> Institutional ownership reported to the SEC as of Q3 2026, from Form 13F filings. Source: https://holderbook.com/stocks/AGL/

- Reporting holders: 3
- Reported value: $34.5K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Farther Finance Advisors, LLC](https://holderbook.com/funds/1992825-farther-finance-advisors-llc/) | $18.2K | 229 | 0.0% | 2 |
| [GAMMA Investing LLC](https://holderbook.com/funds/2010235-gamma-investing-llc/) | $15.9K | 200 | 0.0% | 3 |
| [CoreCap Advisors, LLC](https://holderbook.com/funds/1902501-corecap-advisors-llc/) | $318 | 4 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2026 | 3 | $34.5K |
| Q2 2026 | 181 | $2.0B |
| Q1 2026 | 94 | $128.1M |
| Q4 2025 | 198 | $256.7M |
| Q3 2025 | 191 | $397.2M |
| Q2 2025 | 207 | $931.4M |
| Q1 2025 | 205 | $1.8B |
| Q4 2024 | 194 | $804.0M |
| Q3 2024 | 215 | $1.7B |
| Q2 2024 | 210 | $3.0B |
| Q1 2024 | 207 | $3.4B |
| Q4 2023 | 206 | $6.3B |

